Clinical Trials · NCT03001349
68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors
- Phase
- EARLY_Phase 1
- Recruitment status
- Terminated
- Sponsor
- M.D. Anderson Cancer Center
- Enrollment
- 4
- Start date
- May 2017
- Locations
- 1 site, United States
- Primary endpoint
- Incidence of adverse events